{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:26:20Z","timestamp":1773300380690,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00404-018-4779-4","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T03:08:39Z","timestamp":1524798519000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Breast cancer patients\u2019 satisfaction with individual therapy goals and treatment in a standardized integrative medicine consultancy service"],"prefix":"10.1007","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-7020","authenticated-orcid":false,"given":"Carolin C.","family":"Hack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Antoniadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Langemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Schwitulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Katharin","family":"Theuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"4779_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-0034-1385706","volume":"11","author":"CC Hack","year":"2014","unstructured":"Hack CC, H\u00fcttner NBM, Paepke D et al (2014) Integrative Medizin in der Gyn\u00e4kologischen Onkologie\u2014M\u00f6glichkeiten und Grenzen Teil 1. Senologie Zeitschrift f\u00fcr Mammadiagnostik und therapie 11:217\u2013226","journal-title":"Senologie Zeitschrift f\u00fcr Mammadiagnostik und therapie"},{"key":"4779_CR2","unstructured":"The Bravewell Collaborative (2016). \n                    http:\/\/www.bravewell.org\/integrative_medicine\/\n                    \n                  . Accessed 24 Jul 2016"},{"key":"4779_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1534735411423920","volume":"11","author":"M Horneber","year":"2012","unstructured":"Horneber M, Bueschel G, Dennert G et al (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11:187\u2013203","journal-title":"Integr Cancer Ther"},{"issue":"Suppl 1","key":"4779_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/ijgc-00009577-200602001-00035","volume":"16","author":"A Molassiotis","year":"2006","unstructured":"Molassiotis A, Browall M, Milovics L et al (2006) Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecol Cancer 16(Suppl 1):219\u2013224","journal-title":"Int J Gynecol Cancer"},{"key":"4779_CR5","first-page":"81","volume":"258","author":"K Munstedt","year":"1996","unstructured":"Munstedt K, Kirsch K, Milch W et al (1996) Unconventional cancer therapy\u2014survey of patients with gynaecological malignancy. Arch Gynecol Obstet 258:81\u201388","journal-title":"Arch Gynecol Obstet"},{"key":"4779_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00520-005-0883-7","volume":"14","author":"A Molassiotis","year":"2006","unstructured":"Molassiotis A, Scott JA, Kearney N et al (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14:260\u2013267","journal-title":"Support Care Cancer"},{"key":"4779_CR7","first-page":"34S","volume":"20","author":"LM DiGianni","year":"2002","unstructured":"DiGianni LM, Garber JE, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20:34S\u201338S","journal-title":"J Clin Oncol"},{"key":"4779_CR8","unstructured":"Leitlinienprogramm Onkologie der AWMF DKeVuDKeV (2012) Interdisziplin\u00e4re S3-Leitlinie f\u00fcr die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. In: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF) e.V"},{"key":"4779_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/1534735416668575","author":"CC Hack","year":"2016","unstructured":"Hack CC, Fasching PA, Fehm T et al (2016) Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients in the EvAluate-TM study. Integr Cancer Ther. \n                    https:\/\/doi.org\/10.1177\/1534735416668575","journal-title":"Integr Cancer Ther"},{"key":"4779_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10549-005-9005-y","volume":"95","author":"B Gerber","year":"2006","unstructured":"Gerber B, Scholz C, Reimer T et al (2006) Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 95:199\u2013209","journal-title":"Breast Cancer Res Treat"},{"key":"4779_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00432-013-1460-y","volume":"139","author":"M Paul","year":"2013","unstructured":"Paul M, Davey B, Senf B et al (2013) Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol 139:1515\u20131522","journal-title":"J Cancer Res Clin Oncol"},{"key":"4779_CR12","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.ejca.2012.04.021","volume":"48","author":"E Tautz","year":"2012","unstructured":"Tautz E, Momm F, Hasenburg A et al (2012) Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer 48:3133\u20133139","journal-title":"Eur J Cancer"},{"key":"4779_CR13","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00520-007-0231-1","volume":"15","author":"PA Fasching","year":"2007","unstructured":"Fasching PA, Thiel F, Nicolaisen-Murmann K et al (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 15:1277\u20131284","journal-title":"Support Care Cancer"},{"key":"4779_CR14","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1188\/10.CJON.E45-E55","volume":"14","author":"A Wanchai","year":"2010","unstructured":"Wanchai A, Armer JM, Stewart BR (2010) Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs 14:E45\u2013E55","journal-title":"Clin J Oncol Nurs"},{"key":"4779_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ecc.12095","volume":"23","author":"J Huebner","year":"2014","unstructured":"Huebner J, Rose C, Geissler J et al (2014) Integrating cancer patients\u2019 perspectives into treatment decisions and treatment evaluation using patient-reported outcomes\u2014a concept paper. Eur J Cancer Care (Engl) 23:173\u2013179","journal-title":"Eur J Cancer Care (Engl)"},{"key":"4779_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000360381","volume":"9","author":"J Huebner","year":"2014","unstructured":"Huebner J, Muenstedt K, Prott FJ et al (2014) Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel) 9:60\u201363","journal-title":"Breast Care (Basel)"},{"key":"4779_CR17","first-page":"943","volume":"34","author":"J Huebner","year":"2014","unstructured":"Huebner J, Micke O, Muecke R et al (2014) User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res 34:943\u2013948","journal-title":"Anticancer Res"},{"key":"4779_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1055\/s-2005-837456","volume":"65","author":"K Nicolaisen-Murmann","year":"2005","unstructured":"Nicolaisen-Murmann K, Thiel F, Mohrmann S et al (2005) Complementary and alternative medicine in women with gynecological and breast malignancies\u2014a multicenter study exploring prevalence and motivation. Geburtsh Frauenheilk 65:178\u2013185","journal-title":"Geburtsh Frauenheilk"},{"key":"4779_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000358158","volume":"37","author":"B Koehl","year":"2014","unstructured":"Koehl B, Muenstedt K, Micke O et al (2014) Survey of German non-medical practitioners regarding complementary and alternative medicine in oncology. Oncol Res Treat 37:49\u201353","journal-title":"Oncol Res Treat"},{"key":"4779_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-0035-1545850","volume":"75","author":"CC Hack","year":"2015","unstructured":"Hack CC, H\u00fcttner NB, Fasching PA et al (2015) Development and validation of a standardized questionnaire and standardized diary for use in integrative medicine consultations in gynecologic oncology. Geburtshilfe Frauenheilkd 75:377\u2013383","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"4779_CR21","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1016\/j.ejca.2013.07.017","volume":"49","author":"AR Wilson","year":"2013","unstructured":"Wilson AR, Marotti L, Bianchi S et al (2013) The requirements of a specialist Breast Centre. Eur J Cancer (Oxf Engl 1990) 49:3579\u20133587","journal-title":"Eur J Cancer (Oxf Engl 1990)"},{"key":"4779_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12906-017-1691-6","volume":"17","author":"CE Kim","year":"2017","unstructured":"Kim CE, Shin JS, Lee J et al (2017) Quality of medical service, patient satisfaction and loyalty with a focus on interpersonal-based medical service encounters and treatment effectiveness: a cross-sectional multicenter study of complementary and alternative medicine (CAM) hospitals. BMC Complement Altern Med 17:174","journal-title":"BMC Complement Altern Med"},{"key":"4779_CR23","unstructured":"Hack CC, Beckmann MW, Hein A et al (2014) Einsatz von integrativen Heilmethoden durch postmenopausale Mammakarzinompatientinnen in der PreFace Phase IV Studie\u2014eine prospektive, longitudinale Untersuchung. Geburtshilfe und Frauenheilkunde 74:PO_Onko10_19"},{"key":"4779_CR24","first-page":"85","volume":"7","author":"GE Deng","year":"2009","unstructured":"Deng GE, Frenkel M, Cohen L et al (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7:85\u2013120","journal-title":"J Soc Integr Oncol"},{"key":"4779_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/jncimonographs\/lgu041","volume":"2014","author":"H Greenlee","year":"2014","unstructured":"Greenlee H, Balneaves LG, Carlson LE et al (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014:346\u2013358","journal-title":"J Natl Cancer Inst Monogr"},{"key":"4779_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1472-6963-7-107","volume":"7","author":"T Sundberg","year":"2007","unstructured":"Sundberg T, Halpin J, Warenmark A et al (2007) Towards a model for integrative medicine in Swedish primary care. BMC Health Serv Res 7:107","journal-title":"BMC Health Serv Res"},{"key":"4779_CR27","first-page":"383142","volume":"2013","author":"H Cramer","year":"2013","unstructured":"Cramer H, Cohen L, Dobos G et al (2013) Integrative oncology: best of both worlds\u2014theoretical, practical, and research issues. Evid Based Complement Altern Med 2013:383142","journal-title":"Evid Based Complement Altern Med"},{"key":"4779_CR28","unstructured":"Hannover MH (2015) ZAP satisfaction in outpatient care\u2014quality from the patient's perspective. National Assoc Statutory Health Insurance Phys (KBV)"},{"key":"4779_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1055\/s-0029-1192030","volume":"71","author":"R Kilian","year":"2009","unstructured":"Kilian R, Gonnerman C, Seiler R et al (2009) The development of a questionnaire for the assessment of integrated health-care programmes from the patients\u2019 perspective (BIGPAT). Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 71:460\u2013468","journal-title":"Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))"},{"key":"4779_CR30","first-page":"50","volume":"4","author":"I Scholl","year":"2011","unstructured":"Scholl I, H\u00f6lzel L, H\u00e4rter M et al (2011) Fragebogen zur zufriedenheit in der ambulanten versorgung\u2013schwerpunkt patientenbeteiligung (ZAPA). Klinische Diagnostik und Evaluation 4:50\u201362","journal-title":"Klinische Diagnostik und Evaluation"}],"updated-by":[{"DOI":"10.1007\/s00404-018-4785-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000}}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-018-4779-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:47:55Z","timestamp":1559130475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-018-4779-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4779"],"URL":"https:\/\/doi.org\/10.1007\/s00404-018-4779-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00404-018-4785-6","asserted-by":"object"}]},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this article contained an error in figure\u00a01. It was provided in German.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PAF is a consultant with Amgen, Pfizer, Roche and Novartis. This is not related to any of the topics presented in this article. All other authors hereby declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the survey involving human participants were in accordance with the ethical standards of institutional and national research committee. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}